| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.9B | $14.9B | $13.0B | $11.3B | $9.9B | $8.2B | $8.0B | $7.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $2.1B | $2.1B | $1.7B | $1.5B | $1.4B | $0.8B | $1.0B | $0.9B |
| EPS (Basic) | $10.53 | $9.94 | $8.16 | $7.16 | $6.81 | $5.94 | $7.32 | $5.89 |
| EPS (Diluted) | $10.30 | $9.70 | $7.97 | $6.98 | $6.63 | $5.83 | $7.17 | $5.75 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $88.2B | $83.0B | $78.4B | $81.0B | $61.9B | $47.5B | $38.8B | $37.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $11.4B | $11.0B | $9.3B | $6.2B | $7.2B | $5.4B | $4.0B | $3.5B |
| Total Liabilities | $75.7B | $71.3B | $68.2B | $71.5B | $53.6B | $40.3B | $32.2B | $31.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $12.5B | $11.7B | $10.2B | $9.5B | $8.2B | $7.1B | $6.6B | $6.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.4B | $2.2B | $-3.5B | $0.1B | $6.6B | $4.1B | $0.6B | $1.9B |
| Investing Cash Flow | $-4.3B | $-1.0B | $-0.3B | $-7.2B | $-5.1B | $-5.0B | $-1.9B | $-3.5B |
| Capital Expenditures | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $2.4B | $0.4B | $1.4B | $5.9B | $5.3B | $4.6B | $1.4B | $1.4B |